ARTEMISMED Stock Overview
Engages in the management and operation of multi specialty hospitals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for ARTEMISMED from our risk checks.
Artemis Medicare Services Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹280.05 |
| 52 Week High | ₹304.70 |
| 52 Week Low | ₹141.30 |
| Beta | 0.83 |
| 11 Month Change | 2.19% |
| 3 Month Change | 12.15% |
| 1 Year Change | 69.06% |
| 33 Year Change | 694.47% |
| 5 Year Change | n/a |
| Change since IPO | 1,140.53% |
Recent News & Updates
Recent updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now
Jul 18
Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce
Jul 16After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar
Apr 13Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Jun 14Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Mar 15Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal
Aug 31Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Jul 30Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return
May 13Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture
Jan 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Dec 10There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
Sep 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Jul 01There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
May 11We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt
Mar 16Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?
Jan 22Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Nov 13Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)
Jul 20Shareholder Returns
| ARTEMISMED | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 0.02% | -3.8% | -3.4% |
| 1Y | 69.1% | 38.2% | 27.4% |
Return vs Industry: ARTEMISMED exceeded the Indian Healthcare industry which returned 38.2% over the past year.
Return vs Market: ARTEMISMED exceeded the Indian Market which returned 27.4% over the past year.
Price Volatility
| ARTEMISMED volatility | |
|---|---|
| ARTEMISMED Average Weekly Movement | 6.0% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: ARTEMISMED has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ARTEMISMED's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,991 | Devlina Chakravarty | www.artemishospitals.com |
Artemis Medicare Services Limited engages in the management and operation of multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a multi-specialty hospital located in Gurugram.
Artemis Medicare Services Limited Fundamentals Summary
| ARTEMISMED fundamental statistics | |
|---|---|
| Market cap | ₹38.54b |
| Earnings (TTM) | ₹646.58m |
| Revenue (TTM) | ₹9.17b |
59.6x
P/E Ratio4.2x
P/S RatioIs ARTEMISMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARTEMISMED income statement (TTM) | |
|---|---|
| Revenue | ₹9.17b |
| Cost of Revenue | ₹7.11b |
| Gross Profit | ₹2.05b |
| Other Expenses | ₹1.41b |
| Earnings | ₹646.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.70 |
| Gross Margin | 22.41% |
| Net Profit Margin | 7.05% |
| Debt/Equity Ratio | 32.0% |
How did ARTEMISMED perform over the long term?
See historical performance and comparison